A lot of scientifically bright people...have their money and their minds on this molecule...Large Pharmas have reduced pipeline issues...and our molecule is a platform drug...
I would think, that All of our people have that in mind...when processing the possibilities...Butt,...NASH is definitely first out of the gate...Covid, the flu season, and the new variations...willl keep medical institutions...Very busy.
We have a winner...we just need to enter the race.